imicil injection
syner-med pharmaceuticals (k) ltd icd road, off mombasa road, nairobi - 52096-00200 - imipenem and cilastatin sodium - injection - imipenem 500mg and cilastatin 500mg/vial - beta-lactamantibacterials: carbapenems
inno-cila (imipenem and cilastatin for injection
m/s. innocia lifesciences pvt. ltd. m/s. innocia lifesciences pvt. ltd. 12 balaji - imipenem and cilastatin for injection usp - injection - 500 mg/vial - beta-lactamantibacterials: carbapenems
pelastin powder for injection
pt sanbe farma jl taman sari no.10 bandung indonesia - imipenem & cilastatin for injection usp - powder for injection - imipenem monohydrate equivalent to 500 mg of - beta-lactamantibacterials: carbapenems
imipenem/cilastatin atb 500 mg/500 mg powder for solution for infusion
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - powder for solution for infusion - imipenem 500 mg cilastatin 500 mg - antibacterials for systemic use
recarbrio- imipenem anhydrous, cilastatin, and relebactam anhydrous injection, powder, for solution
merck sharp & dohme llc - imipenem anhydrous (unii: q20im7he75) (imipenem anhydrous - unii:q20im7he75), cilastatin (unii: 141a6amn38) (cilastatin - unii:141a6amn38), relebactam anhydrous (unii: 1oqf7tt3pf) (relebactam anhydrous - unii:1oqf7tt3pf) - recarbrio™ is indicated for the treatment of patients 18 years of age and older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia, caused by the following susceptible gram-negative microorganisms: acinetobacter calcoaceticus-baumannii complex, enterobacter cloacae , escherichia coli , haemophilus influenzae , klebsiella aerogenes, klebsiella oxytoca, klebsiella pneumoniae, pseudomonas aeruginosa, and serratia marcescens. recarbrio is indicated in patients 18 years of age and older who have limited or no alternative treatment options, for the treatment of complicated urinary tract infections (cuti), including pyelonephritis, caused by the following susceptible gram-negative microorganisms: enterobacter cloacae , escherichia coli , klebsiella aerogenes, klebsiella pneumoniae, and pseudomonas aeruginosa . approval of this indication is based on limited clinical safety and efficacy data for recarbrio [see clinical studies (14.2)] . recarbrio is indicated in patients
tienam 500 for injection
msd pharma (singapore) pte. ltd. - cilastatin sodium eqv cilastatin; imipenem - injection, powder, for solution - 500 mg/vial - cilastatin sodium eqv cilastatin 500 mg/vial; imipenem 500 mg/vial
primaxin iv 500mg/500mg powder for solution for infusion
merck sharp & dohme limited hertford road, hoddesdon, hertfordshire en11 9bu, united kingdom - cilastatin, imipenem - powder for solution for infusion - cilastatin 500 mg imipenem 500 mg - antibacterials for systemic use
imipenem/cilastatine stravencon 250mg/250mg, poeder voor oplossing voor infusie
imipenem/cilastatine stravencon 500mg/500mg, poeder voor oplossing voor infusie
imistin 2g injection
zawadi healthcare ltd zawadi healthcare ltd maua close westlands - imipenam + cilastatin - injection - imipenem 1000mg /(i gram) + cilastatin 1000mg / 1 - imipenem and enzyme inhibitor